Marc Ferrante
UZ Leuven · IG/MAAG-DARM-LEVER, UZ Leuven, campus Gasthuisberg, Herestraat 49 3000 Leuven · Universitaire Ziekenhuizen KU Leuven
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Ferrante as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06338930 · Remote Monitoring of Patients With an Inflammatory Bowel Disease Under no or Maintenance TherapyUniversitaire Ziekenhuizen KU Leuven · not yet recruiting · Crohn Disease, Colitis, Ulcerative, Inflammatory Bowel Diseases · principal investigator
- N/ANCT05944068 · The Effects of a Mindfulness Based Intervention on IBD DisabilityUniversitaire Ziekenhuizen KU Leuven · unknown · Crohn Disease · principal investigator
- Ph4NCT05169593 · Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological TherapyUniversitaire Ziekenhuizen KU Leuven · recruiting · Crohn Disease · principal investigator
- Ph4NCT04982172 · Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel DiseasesUniversitaire Ziekenhuizen KU Leuven · completed · Inflammatory Bowel Diseases · principal investigator
- Ph3NCT04089345 · Stelara fOr ChRonic AntibioTic rEfractory pouchitiSUniversitaire Ziekenhuizen KU Leuven · completed · Pouchitis · principal investigator
- N/ANCT03142113 · Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative ColitisUniversitaire Ziekenhuizen KU Leuven · completed · Ulcerative Colitis · principal investigator
- N/ANCT02914717 · The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative ColitisUniversitaire Ziekenhuizen KU Leuven · completed · Ulcerative Colitis · principal investigator
- Ph4NCT02910375 · Golimumab Dried Blood Spot AnalysisUniversitaire Ziekenhuizen KU Leuven · unknown · Ulcerative Colitis · principal investigator
- N/ANCT02634060 · Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction DestinyUniversitaire Ziekenhuizen KU Leuven · completed · Crohn Disease, Colitis, Ulcerative · principal investigator
- Ph3NCT01541579 · Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's DiseaseTigenix S.A.U. · completed · Crohn's Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:48 UTC. The ranking covers the 200 most relevant of 69 PubMed records, and a shared surname and initials can bring in a namesake. All 69 on PubMed
- 845 citationsRCR 33.2
- Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.Gastroenterology · 2015761 citationsRCR 31.5
- 450 citationsRCR 13.7
- 393 citationsRCR 13.9
- 384 citationsRCR 33.4
- Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.Gastroenterology · 2018367 citationsRCR 16.3
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.Gut · 2009339 citationsRCR 7.8
- 314 citationsRCR 27.2
- Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.Gastroenterology · 2020224 citationsRCR 13.2
- Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.Gastroenterology · 2020195 citationsRCR 9.7